Top compounds associated with response to MCFD2


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.21 3e-11
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.22 3e-10
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.21 1e-09
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.21 2e-09
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.19 2e-09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.21 2e-09
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.2 2e-09
mRNA dinaciclib CTRPv2 pan-cancer AAC -0.29 4e-09
mRNA lovastatin CTRPv2 pan-cancer AAC 0.23 6e-09
mRNA vincristine CTRPv2 pan-cancer AAC -0.18 9e-09
Download CSV